Natalia Barajas Castrellon: FRONTIER2 Results Show Potential for Prophylactic Therapy in Hemophilia A
Natalia Barajas Castrellon, Rared Associate Director Medical and Marketing at Novo Nordisk, reposted from Novo Nordisk on LinkedIn:
”New data from Novo Nordisk in hemophilia A, published in NEJM Group, reinforces the strategic direction of the portfolio.
The results highlight the potential of an investigational prophylactic therapy to reduce bleeding episodes across patient segments, including those with inhibitors – while enabling greater treatment individualization, a key driver of next-generation care models.
This builds on well-established progress in hemophilia, where advances in prophylaxis have materially improved quality of life and extended life expectancy toward that of the general population.”
Novo Nordisk shared on LinkedIn about a recent article by Maria Elisa Mancuso et al, published in NEJM, adding:
”Results from Novo Nordisk’s hemophilia research published in NEJM Group highlights the potential of an investigational preventive bleed treatment option to help people living with hemophilia A, with or without inhibitors.
Learn more in the press release.”
Title: Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
Authors: Maria Elisa Mancuso, Anthony K.C. Chan, Chandrakala Shanmukhaiah, Chuhl Joo Lyu, Joanna Zdziarska, Johnny Mahlangu, Lize F.D. van Vulpen, Pratima Chowdary, Renchi Yang, Steven R. Lentz, Tadashi Matsushita, Wan Hui Ong Clausen, Ilgiz Rakhmatullin, Johannes Oldenburg for the FRONTIER2 Investigators
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy